NHS Scotland allows patients to use a community pharmacy as their first point of contact to receive a range of Health Board, Public Health and Pandemic services on the NHS. A range of services are available including emergency contraception, smoking cessation and gluten-free food dispensing. The Clinical Pharmacy Services (CPS) module of ProScript Connect enables […]
From 1st May 2024 for the products and packs listed in the table below, the VMPPs and AMPPs in dm+d are being updated to express the new pack volumes as the ‘Usable Volumes’ in dm+d and in Part VIIIA of the Drug Tariff May 2024. Where an SmPC for an oral solution or oral suspension […]
There will be intermittent supply of all strengths of lisdexamfetamine (Elvanse®) capsules until April 2024. Supplies of various strengths of Elvanse® will be available at different times throughout this period. Generic dexamfetamine 5mg tablets and Amfexa® (dexamfetamine) 5mg, 10mg, and 20mg tablets remain available but are unable meet large increases in demand. Unlicensed supplies of […]
From 1st April 2024, the pack size listings of Xarelto® (Rivaroxaban) 1mg/ml granules for oral suspension have been updated to reflect the volume of water added for reconstitution (rather than bottle sizes). The 250ml bottle has now been updated to 100ml (volume of water added for reconstitution) in the April 2024 Drug Tariff and DMD (licensed […]
Sodium Valproate – Special Container dispensing Following the change in special container status to whole pack dispensing for all licensed medicines containing sodium valproate, valproic acid and semi sodium valproate, sites have reported issues in dispensing certain sodium valproate prescriptions as they are unable to obtain stock of all pack sizes. This wasn’t an […]
Changes to Northern Ireland Special Container Rules HSCNI (Health and Social Care Northern Ireland) has recently informed us that following the change in special container status for all licensed medicines containing sodium valproate, valproic acid and semi sodium valproate, they have updated their special container payment rules. These updates to the rules require work in […]
Sanofi will be out of stock of clomifene (Clomid®) 50mg tablets from w/c 12 June 2023 until w/c 18 September 2023. Generic clomifene 50mg tablets remain available from Wockhardt who are able to partially uplift supplies until end of July 2023. If required, unlicensed supplies may be sourced. If dispensing the unlicensed product the following […]
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Paracetamol suppositories: Paracetamol 60mg suppositories are out of stock until w/c 1st April 2024 Paracetamol 125mg suppositories are out of stock until October 2023. Paracetamol 240mg suppositories are out of stock until w/c 10th July 2023. Paracetamol 250mg suppositories will be […]
Diazepam 10mg/2.5ml rectal solution tubes will be out of stock from mid-July until mid-August 2023. Unlicensed supplies of diazepam 10mg/2.5ml rectal solution tubes may be sourced. If dispensing the unlicensed product the following guidance should be followed to ensure correct reimbursement: Paper Prescriptions If dispensing the unlicensed product on a paper prescription, the prescription should be […]
We are currently reviewing changes that will be required to the ProScript Connect (PSC) application in response to the Community Pharmacy Contractual Framework (CPFC) Year 4 announcements. Until these enhancements are implemented, this page will help assist pharmacy contractors in England to meet the requirements of the CPCF through PSC. Further information can be found on the PSNC […]
Selegiline (Eldepryl®) 5mg and 10mg tablets are out of stock until April 2023. Currently Rasagiline 1mg tablets remain available along with Selegiline oral suspensions through specials manufacturers. If these products are not suitable unlicensed supplies of selegiline (Eldepryl®) 5mg and 10mg tablets may be sourced. If dispensing the unlicensed product the following guidance should be […]
Dear Pharmacist, The NHS Business Services Authority occasionally make changes to existing SNOMED codes (which are used for electronic prescribing) as part of bringing this information in line with the dm+d Editorial Policy (see under dm+d Resources). The NHSBSA are making changes to AMP codes for a number of ACBS products over the coming months. Until the codes have been updated on […]
Endorsement Guidance for SSP034 Combisal® 125mcg/25mcg inhalers NHSBSA have announced a substitution SSP for Combisal (Fluticasone 125microgram / Salmeterol 25microgram) pressurised metered dose inhaler (pMDI). If the inhaler cannot be supplier another Fluticasone 125microgram / Salmeterol 25microgram pMDI can be supplied instead If a patient uses a spacer with their inhaler, the pharmacist should attempt to […]
Hypertension Case Finding Service The Hypertension case finding service has been commissioned as an Advanced service from 1st October 2021. The service involves identifying people aged 40 years or older with high blood pressure, who have previously not had a confirmed diagnosis of hypertension, and to refer them to general practice to confirm diagnosis and […]
Pharmacy First Rejected Items Community Pharmacy Scotland (CPS) have recently communicated an increased number of disallowed items for the NHS Pharmacy First Scotland service resulting in claims for these items rejected for reimbursement. The majority of these rejections were due to a technical issue and further information can be found on the CPS website. Items may […]
For the purposes of the guidance, the scenarios below are test examples. You must always refer to the latest SSP information. Background Serious Shortage Protocols (SSPs) are an exemption to regulation 214 of the Human Medicines Regulations 2012, which allow pharmacies to manage serious shortages of medicines. Once an SSP has been issued by the […]
Please note there has been a change on NHSBSA dm+d browser for the listing of Colecalciferol 1,000units/ml oral drops sugar free. The concept for 1,000units/ml strength has been discontinued and replaced by Colecalciferol 1,000units/drop oral drops sugar free. There will no longer be an option to select 1,000units/ml strength from the ‘Select prescribed item’ screen on ProScript Connect and for electronic prescriptions the product will […]
The UK FMD Working Group has issued an update for Healthcare Professionals involved with FMD across the UK. Now that the UK has left the EU and the Transition Period ends on 31st December 2020, some regulatory requirements will no longer apply. However, certain EU legislation will continue to have effect in Northern Ireland under the Northern Ireland Protocol […]
From October 2021 contractors must endorse the number of SSP claims made each month on the FP34C form. This declaration will not be used for reimbursement but to indicate SSP claim(s) were made in the month. Please note this is a declaration of the claims and not the number of items dispensed in accordance with […]
Licensed products by Rosemont are now available for both Venlafaxine 37.5mg/5ml oral solution sugar free and Venlafaxine 75mg/5ml oral solution sugar free. In order to be reimbursed correctly for the product that you have dispensed, the following guidance should be followed. Paper Prescriptions In order to dispense and be reimbursed for the licensed product, the […]
The Hypertension case finding service has been commissioned as an Advanced service from 1st October 2021. The service involves identifying people aged 40 years or older with high blood pressure, who have previously not had a confirmed diagnosis of hypertension, and to refer them to general practice to confirm diagnosis and for appropriate management. Further information […]
CPCF 2021/2022 Details for the Pharmacy Quality Scheme (PQS) which forms part of the Community Pharmacy Contractual Framework (CPCF) have been published. This page contains information to help assist pharmacy contractors in England to meet the requirements of the CPCF through ProScript Connect (PSC). Further information can be found on the PSNC website. Respiratory Domain Return […]
NMS Expansion: September 2021 Background From 1st September 2021, contractors can provide the New Medicines Service (NMS) to patients that are newly prescribed medicines for the following additional conditions: Acute coronary syndrome (ACS); Atrial fibrillation (AF); Coronary heart disease; Epilepsy; Glaucoma; Gout; Heart failure; Hypercholesterolaemia ; Long term risks of venous thromboembolism/embolism; Osteoporosis; Parkinson’s Disease; Stroke / […]
Dear Pharmacist As part of the Quality and Safety Scheme, pharmacies are required to complete a High Risk Medicines information survey. This involves providing information on the number of patients whose prescriptions were dispensed in the pharmacy during a specified time period based on certain conditions outlined in the link below: http://www.cpwales.org.uk/Services-and-commissioning/Quality-Scheme/High-Risk-Medicines-Survey-2021-22.aspx Quality and Safety […]
Dear Pharmacist, The NHS Business Services Authority have made changes to existing VMP SNOMED codes which are used for electronic prescribing. Due to the code changes, some prescribing systems may still be issuing electronic prescriptions using the inactive VMP SNOMED codes in the near future. What this means is that any affected products will not […]
Dispensing Omeprazole oral suspension Guide
FP10 Update – Changes to Exemption Document
EPS Phase 4 now live All dispensers need to be aware that they could now receive an EPS Phase 4 token from a patient. GP practices can now use EPS for patients without a nomination, with patients receiving a Phase 4 token with a scannable barcode instead of a signed FP10. All four GP system […]
Live SSPs
The following legislative changes will apply from Monday 1st April 2019: ◼ Gabapentin will become a Schedule 3 controlled drug (CD No Register POM), but will be exempt from safe custody regulations ◼ Pregabalin will become a Schedule 3 controlled drug (CD No Register POM), but will be exempt from safe custody regulations Reclassification of […]